Effect of cinnamoyl and flavonol glucosides derived from cherry blossom flowers on the production of advanced glycation end products (AGEs) and AGE-induced fibroblast apoptosis

Phytotherapy Research

Volumn 25, Issue 9, 2011, Pages 1328-1335

  Shimoda, Hiroshi ^a   Nakamura, Seiko ^b   Morioka, Makoto ^b   Tanaka, Junji ^a   Matsuda, Hisashi ^b   Yoshikawa, Masayuki ^b  

^a 1 Numata Kitagata cho   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

advanced glycation end product; caffeoyl glucose; cherry blossom; collagen lattice; fibroblast; quercetin glucoside

Indexed keywords

1 O CAFFEOYL BETA DEXTRO GLUCOPYRANOSIDE; 1 O CINNAMOYL BETA DEXTRO GLUCOPYRANOSIDE; 1 O COUMAROYL BETA DEXTRO GLUCOPYRANOSIDE; 6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; BOVINE SERUM ALBUMIN; CAFFEIC ACID; CINNAMIC ACID; CINNAMOYL GLUCOSIDE; COLLAGEN; COUMARIC ACID; FLAVONOL GLUCOSIDE; GLUCOSE; GLUCOSIDE; GLYOXAL; KAEMPFEROL; KAEMPFEROL 3 O (6'' MALONYL) BETA DEXTRO GLUCOPYRANOSIDE; KAEMPFEROL 3 O BETA DEXTRO GLUCOPYRANOSIDE; PLANT EXTRACT; PRUNUS LANNESIANA EXTRACT; QUERCETIN; QUERCETIN 3 O (6'' MALONYL) BETA DEXTRO GLUCOPYRANOSIDE; QUERCETIN 3 O BETA DEXTRO GLUCOPYRANOSIDE; UNCLASSIFIED DRUG; 1,4-DI-O-(E)-CAFFEOYL-BETA-D-GLUCOPYRANOSIDE; CAFFEIC ACID DERIVATIVE; FLAVONOL DERIVATIVE; QUERCETIN 3-O-GLUCOPYRANOSIDE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; FIBROBLAST; FLOWER; GLYCATION; HUMAN; HUMAN CELL; IC 50; PRUNUS; PRUNUS LANNESIANA; ANALOGS AND DERIVATIVES; CELL LINE; CHEMISTRY; DRUG EFFECTS; METABOLISM;

PRUNUS SERRULATA VAR. LANNESIANA;

APOPTOSIS; CAFFEIC ACIDS; CELL LINE; COLLAGEN; FIBROBLASTS; FLAVONOLS; FLOWERS; GLUCOSIDES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; PLANT EXTRACTS; PRUNUS; QUERCETIN;

EID: 80052295589     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3423     Document Type: Article

References (41)

1. Abdallah OM, Kamel MS, Mohamed MH,. 1994. Phenylpropanoid glycosides of Prunus ssiori. Phytochemistry 37: 1689-1692.
2. Alhamadani MSS, Al-Azzawie HF, Abbas FKH,. 2007. Decreased formation of advanced glycation end-products in peritoneal fluid by carnosine and related peptide. Perit Dial Int 27: 86-89. (Pubitemid 46403289)
3. Alikhani M, MacLellan CM, Raptis M, et al,. 2006. Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor. Am J Physiol Cell Physiol 292: 850-856.
4. Alikhani Z, Alikhani M, Boyd CM, et al,. 2005. Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways. J Biol Chem 280: 12087-12095.
5. Baderschneider B, Winterhalter P,. 2001. Isolation and characterization of novel benzoates, cinnamates, flavonoids, and lignans from riesling wine and screening for antioxidant activity. J Agric Food Chem 49: 2788-2798. (Pubitemid 32826069)
6. Beaulieu LP, Harris CS, Saleem A, et al,. 2010. Inhibitory effect of the Cree traditional medicine wiishichimanaanh (Vaccinium vitis-idaea) on advanced glycation endproduct formation: identification of active principles. Phytother Res 24: 741-747.
7. Dyer DG, Dunn JA, Thorpe SR, et al,. 1993. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91: 2463-2469. (Pubitemid 23182497)
8. ε-(carboxymethyl)lysine formation. Ann NY Acad Sci 1126: 152-154. (Pubitemid 351589277)
9. Ha HD, Ngoc TM, Lee I, et al,. 2009. Inhibitor of aldose reductase and formation of advanced glycation end-products in moutan cortex (Paeonia sffruticosa). J Nat Prod 72: 1465-1470.
10. Hiradate S, Morita S, Sugie H, et al,. 2004. Phytotoxic cis-cinnamoyl glucosides from Spiraea thunbergii. Phytochemistry 65: 731-739. (Pubitemid 38315134)
11. Huebschmann AG, Regensteiner JG, Vlassara H, et al,. 2006. Diabetes and advanced glycoxidation end products. Diab Care 29: 1420-1432. (Pubitemid 44125953)
12. Huet E, Vallée B, Szul D, et al,. 2008. Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing α-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling. FASEB J 22: 1144-1154. (Pubitemid 351519969)
13. Jakus V,. 2000. The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease. Bratisl Lek Listy 101: 541-551.
14. Jang DS, Lee GY, Kim YSK, et al,. 2007. Anthraquinones from the seeds of Cassia tora with inhibitory activity on protein glycation and aldose reductase. Biol Pharm Bull 30: 2207-2210. (Pubitemid 350097056)
15. Kern TS, Engerman RL,. 2001. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes 50: 1636-1642. (Pubitemid 33639605)
16. Kueper T, Grune T, Prahl S, et al,. 2007. Vimentin is the specific target in skin glycation. Structural prerequisites, functional consequences, and role in skin aging. J Biol Chem 282: 23427-23436. (Pubitemid 47311904)
17. Lee EH, Song DG, Lee JY, et al,. 2008. Inhibitory effect of the compounds isolated from Rhus verniciflua on aldose reductase and advanced glycation endproducts. Biol Pharm Bull 31: 1626-1630.
18. Lee S, Lee KW,. 2007. Protective effect of (-)-epigallocatechin gallate against advanced glycation endproducts-induced injury in neuronal cells. Biol Pharm Bull 30: 1369-1373. (Pubitemid 47282177)
19. Lohwasser C, Neureiter D, Weigle B, et al,. 2006. The receptor for advance glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J Invest Dermatol 126: 291-299. (Pubitemid 43323163)
20. Lv L, Shao X, Wang L, Huang D, et al,. 2010. Stilbene glucoside from polygonum multiflorum Thunb.: A novel natural inhibitor of advanced glycation end product formation by trapping of methylglyoxal. J Agric Food Chem 58: 2239-2245.
21. Markham KR, Ternal B, Stanley R, et al,. 1978. Direct proton and natural abundance carbon-13 NMR observation of liver changes induced by ethionine. Tetrahedron 34: 1389-1397.
22. Matsuda H, Wang T, Managi H, et al,. 2003. Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activity. Bioorg Med Chem 11: 5317-5323. (Pubitemid 37464658)
23. Matsuura R, Moriyama H, Takeda N, et al,. 2008. Determination of antioxidant activity and characterization of antioxidant phenolics in the plum vinegar extract of cherry blossom (Prunus lannesiana). J Agric Food Chem 56: 544-549. (Pubitemid 351212583)
24. ε-(carboxymethyl) lysine, one of the glycoxidation products of the Maillard reaction. J Invest Dermatol 108: 797-802. (Pubitemid 27192356)
25. Nakamura K, Nakazawa Y, Ienaga K., 1997. Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose. Biochem Biophys Res Commun 232: 227-230. (Pubitemid 27211953)
26. Noshita T, Sakaguchi A, Funayama S,. 2006. Isolation of ethyl caffeate from the petal of Prunus yedoensis. J Nat Med 60: 266-267.
27. Obayashi H, Nakano K, Shigeta H, et al,. 1996. Formation of crosslines as a fluorescent advanced glycation end product in vitro and in vivo. Biochem Biophys Res Commun 226: 37-41. (Pubitemid 26332161)
28. Pageon H, Bakala H, Monnier VM, et al,. 2007. Collagen glycation triggers the formation of aged skin in vitro. Eur J Dermatol 17: 12-20. (Pubitemid 46383214)
29. Peng X, Cheng KW, Ma J, et al,. 2008. Cinnamon bark proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advanced glycation endproducts. J Agric Food Chem 56: 1907-1911. (Pubitemid 351497845)
30. Sakamura F,. 1992. Chemical components of Prunus yedoensis fruit. J Home Econ Jpn 43: 215-217.
31. Sang S, Shao X, Bai N, et al,. 2007. Tea polyphenol (-)-epigallocatechin- 3-gallate: a new trapping agent of reactive dicarbonyl species. Chem Res Toxicol 20: 1862-1870.
32. Shimomura H, Sashida Y, Adachi T,. 1987. Phenolic glucoside from Prunus grayana. Phytochemistry 27: 249-251.
33. Shimomura H, Sashida Y, Adachi T,. 1988. Phenyl propanoid glucose esters from Prunus buergeriana. Phytochemistry 27: 641-644.
34. Sourris KC, Harcourt BE, Forbes JM,. 2009. A new perspective on therapeutic inhibition of advanced glycation in diabetic microvascular complications: common downstream endpoints achieved through disparate therapeutic approaches? Am J Nephrol 30: 323-335.
35. Tessier F, Obrenovich M, Monnier VM,. 1999. Structure and mechanism of formation of human lens fluorophore LM-1. J Biol Chem 274: 20796-20804.
36. Thornalley PJ,. 2008. Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems-role in ageing and disease. Drug Metabol Drug Interact 23: 125-150. (Pubitemid 351669568)
37. Villegas RJA, Kojima M,. 1985. Sweet potato root enzyme which catalyzes the formation of chlorogenic acid from 1-O-caffeoyl- d -glucose and d -quinic acid. Agric Biol Chem 49: 263-265.
38. Wald B, Wray V, Galensa R, et al,. 1989. Malonated flavonol glycosides and 3,5-dicaffeoylquinic acid from pears. Phytochemistry 28: 663-664.
39. Wanga W, Zenga SF, Yanga CR, et al,. 2009. A new hydrolyzable tannin from Balanophora harlandii with radical-scavenging activity. Helv Chim Acta 92: 1817-1822.
40. Wondrak GT, Roberts MJ, Jacobson MK, et al,. 2002. Photosensitized growth inhibition of cultured human skin cells: mechanism and suppression of oxidative stress from solar irradiation of glycated proteins. J Invest Dermatol 119: 489-498. (Pubitemid 35001962)
41. Yamabe N, Kang KS, Park CH, et al,. 2009. 7-O-galloyl- d -sedoheptulose is a novel therapeutic agent against oxidative stress and advanced glycation endproducts in the diabetic kidney. Biol Pharm Bull 32: 657-664.